 NEW ORLEANS--BUSINESS WIRE--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick Foti, LLC KSF are investigating the proposed merger of Akers Biosciences, Inc. NasdaqCM: AKER with MyMD Pharmaceuticals, Inc., pursuant to which Akers shareholders will end up owning just 20 of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you 